About the Ocular Oncology and Orbital Tumors Session
Managing malignancies of the eye and surrounding structures demands early detection and highly individualized treatment strategies. The field of ocular oncology and orbital tumors brings together diagnostic imaging, histopathology, and molecular profiling to improve patient outcomes. From retinoblastoma in children to ocular melanomas and lymphoproliferative lesions in adults, these conditions require a multidisciplinary approach involving oncologists, ophthalmologists, and radiologists. Technological advances in orbital imaging and targeted therapy are allowing for more conservative treatment plans, reducing the need for enucleation while preserving vision and aesthetics. Surgical precision in orbital tumor resection continues to improve with intraoperative navigation tools. Moreover, attention is growing around survivorship care, addressing both visual rehabilitation and cosmetic reconstruction. As researchers uncover genetic markers and develop immunotherapeutic options, the prognosis for orbital and intraocular tumors is gradually improving, highlighting the need for continued collaboration across oncology and vision science disciplines.
Topics Covered in Ocular Oncology and Orbital Tumors
Retinoblastoma
Uveal Melanoma
Ocular Adnexal Lymphoma
Orbital Tumor Imaging
Molecular Tumor Profiling
Globe-Sparing Therapy
Related Scientific Sessions at IOC 2027
Why Attend the Ocular Oncology and Orbital Tumors Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Ocular Oncology and Orbital Tumors work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Ocular Oncology and Orbital Tumors research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Ocular Oncology and Orbital Tumors track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ocular Oncology and Orbital Tumors Conference 2027 — FAQs
What is the Ocular Oncology and Orbital Tumors track at IOC 2027?
The Ocular Oncology and Orbital Tumors track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ocular Oncology and Orbital Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ocular Oncology and Orbital Tumors sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ocular Oncology and Orbital Tumors are all welcome — whether presenting or attending.
Can I present my research in the Ocular Oncology and Orbital Tumors track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ocular Oncology and Orbital Tumors sessions?
Yes. IOC 2027 is a hybrid conference — attend the Ocular Oncology and Orbital Tumors track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.